The agreement represents another step in Callan JMB's strategy of developing the Atlas Complex as an integrated healthcare and life sciences campus where organizations can establish operations while leveraging shared operational infrastructure and specialized support services.

Under a long-term operational support agreement, Callan JMB will provide the infrastructure and operational services supporting Cavalry 1838's commercialization activities. Pursuant to the agreement, the Company is entitled to receive 60% of revenue generated by the enterprise, expanding Callan JMB's recurring infrastructure services business.

The Atlas Complex provides organizations with access to integrated operational infrastructure, including regulatory compliance, quality systems, logistics, warehousing, distribution and administrative support. By leveraging these shared resources, organizations can reduce capital requirements while focusing on research, product development and commercialization.

Cavalry 1838 is developing an equine-derived biologics enterprise focused on producing pharmaceutical-grade serum, plasma, and specialty biologic products used by pharmaceutical manufacturers, biotechnology companies, veterinary biologics developers, and research organizations. The enterprise is designed to commercialize in phases, beginning with serum and plasma production before expanding into higher-value biologic products and specialty therapeutic applications.

"Every organization that establishes operations at the Atlas Complex has the potential to expand Callan JMB's portfolio of recurring infrastructure and operational services," said Wayne Williams, President and CEO of Callan JMB. "Our strategy is to provide the regulatory, logistics, quality and operational expertise organizations need to commercialize innovative products while allowing them to remain focused on science, manufacturing and product development. As the Atlas Complex continues to evolve, we believe this shared operational approach positions Callan JMB to build long-term service relationships across multiple healthcare and life sciences sectors."

Cavalry 1838's Alabama operations will be located at the Atlas Complex through the campus Equine Center. The Equine Center supports specialized life sciences, veterinary, biologics, and research initiatives requiring professionally managed equine facilities integrated with pharmaceutical-grade operational infrastructure.

Callan JMB will provide the operational support functions necessary to support commercialization, including:

Regulatory compliance and quality management systems
Logistics and supply chain management
Warehousing and distribution
Administrative and shared business services
Scientific and operational support
Commercialization support
Operational infrastructure management

The proposed enterprise is expected to initially operate with Alabama serving as the corporate headquarters and operational support center and Kansas serving as the primary serum collection and production facility. Alabama operations at the Atlas Complex are expected to include research and development, quality control, regulatory management, distribution activities, and the campus Equine Center.

Each organization that establishes operations at the Atlas Complex has the potential to expand Callan JMB's portfolio of recurring infrastructure and operational services while reinforcing the Company's long-term strategy of supporting multiple organizations through a common operational infrastructure.

Cavalry 1838 represents another organization leveraging the Atlas Complex's integrated operational infrastructure. Management continues to evaluate additional opportunities to expand the campus through strategic relationships with organizations operating in pharmaceutical manufacturing, biologics, healthcare logistics, medical research, and related life sciences sectors.